Revolution Medicines (RVMD) Revenue (2019 - 2023)

Revolution Medicines' Revenue history runs 5 years deep, the most recent figure standing at $742000.0 for Q4 2023.

• In Q4 2023, Revenue fell 95.16% year-over-year to $742000.0; the TTM figure through Sep 2024 stood at $742000.0 (down 97.16% YoY), while the FY2023 annual figure was $11.6 million, down 67.27% from the prior year.
• Revenue was $742000.0 for Q4 2023 at Revolution Medicines, down from $3.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $15.3 million in Q4 2022 to a low of $742000.0 in Q4 2023.
• Historically, Revenue has averaged $8.9 million across 5 years, with a median of $9.5 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Revenue soared 204.81% in 2022, then plunged 95.16% in 2023.
• A 5-year view of Revenue shows it stood at $12.1 million in 2019, then retreated by 27.61% to $8.8 million in 2020, then advanced by 8.1% to $9.5 million in 2021, then soared by 62.05% to $15.3 million in 2022, then slumped by 95.16% to $742000.0 in 2023.
• The last three Revenue figures came in at $742000.0 (Q4 2023), $3.8 million (Q2 2023), and $7.0 million (Q1 2023), per Business Quant data.